Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allergan licenses retinal disease treatment from Molecular Partners in $420 million deal
Allergan licenses retinal disease treatment from Molecular Partners in $420 million deal
Allergan licenses retinal disease treatment from Molecular Partners in $420 million deal
Submitted by
admin
on May 4, 2011 - 8:45pm
Source:
Yahoo/AP
News Tags:
Allergan
Molecular Partners
retinal disease
Headline:
Allergan licenses retinal disease treatment from Molecular Partners in $420 million deal
Do Not Allow Advertisers to Use My Personal information
